News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,903 Results
Type
Article (14412)
Company Profile (101)
Press Release (255390)
Multimedia
Podcasts (48)
Webinars (10)
Section
Business (88778)
Career Advice (497)
Deals (15506)
Drug Delivery (67)
Drug Development (37559)
Employer Resources (56)
FDA (6431)
Job Trends (6299)
News (152136)
Policy (14223)
Tag
Academia (481)
Accelerated approval (2)
Adcomms (6)
Allergies (38)
Alliances (23396)
ALS (37)
Alzheimer's disease (403)
Antibody-drug conjugate (ADC) (46)
Approvals (6468)
Artificial intelligence (113)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4453)
BIOSECURE Act (9)
Biosimilars (60)
Biotechnology (40)
Bladder cancer (23)
Brain cancer (16)
Breast cancer (86)
Cancer (671)
Cardiovascular disease (81)
Career advice (435)
Career pathing (12)
CAR-T (26)
Cell therapy (100)
Cervical cancer (4)
Clinical research (31703)
Collaboration (356)
Compensation (155)
Complete response letters (17)
COVID-19 (842)
CRISPR (22)
C-suite (127)
Cystic fibrosis (37)
Data (691)
Denatured (16)
Depression (12)
Diabetes (83)
Diagnostics (1352)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (62)
Drug pricing (69)
Drug shortages (12)
Duchenne muscular dystrophy (40)
Earnings (32561)
Editorial (15)
Employer branding (5)
Employer resources (47)
Events (38032)
Executive appointments (403)
FDA (6873)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (226)
Gene editing (41)
Generative AI (9)
Gene therapy (112)
GLP-1 (367)
Government (1366)
Grass and pollen (3)
Guidances (20)
Healthcare (3711)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (44)
Indications (14)
Infectious disease (881)
Inflammatory bowel disease (56)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (65)
IPO (5946)
IRA (29)
Job creations (2066)
Job search strategy (395)
Kidney cancer (7)
Labor market (13)
Layoffs (191)
Leadership (5)
Legal (3449)
Liver cancer (19)
Lung cancer (89)
Lymphoma (61)
Machine learning (2)
Management (19)
Manufacturing (167)
MASH (33)
Medical device (1365)
Medtech (1367)
Mergers & acquisitions (9779)
Metabolic disorders (275)
Multiple sclerosis (24)
NASH (14)
Neurodegenerative disease (27)
Neuropsychiatric disorders (11)
Neuroscience (605)
NextGen: Class of 2025 (1625)
Non-profit (627)
Now hiring (8)
Obesity (159)
Opinion (125)
Ovarian cancer (22)
Pain (53)
Pancreatic cancer (16)
Parkinson's disease (47)
Partnered (9)
Patents (123)
Patient recruitment (30)
Peanut (11)
People (29122)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8328)
Phase II (13392)
Phase III (12006)
Pipeline (494)
Policy (76)
Postmarket research (1420)
Preclinical (3303)
Press Release (26)
Prostate cancer (48)
Psychedelics (9)
Radiopharmaceuticals (121)
Rare diseases (174)
Real estate (2655)
Recruiting (20)
Regulatory (10260)
Reports (17)
Research institute (583)
Resumes & cover letters (60)
Rett syndrome (1)
RNA editing (2)
RSV (10)
Schizophrenia (39)
Series A (41)
Series B (14)
Service/supplier (3)
Sickle cell disease (32)
Special edition (7)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1646)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (34)
The Weekly (30)
Vaccines (179)
Venture capitalists (15)
Weight loss (110)
Women's health (8)
Worklife (4)
Date
Today (63)
Last 7 days (270)
Last 30 days (937)
Last 365 days (12032)
2025 (3994)
2024 (12781)
2023 (14566)
2022 (19905)
2021 (20510)
2020 (19360)
2019 (15171)
2018 (11989)
2017 (14065)
2016 (13323)
2015 (15681)
2014 (12566)
2013 (10685)
2012 (11508)
2011 (12037)
2010 (10974)
Location
Africa (319)
Alabama (14)
Alaska (1)
Arizona (56)
Arkansas (3)
Asia (20351)
Australia (2664)
California (1830)
Canada (942)
China (254)
Colorado (76)
Connecticut (71)
Delaware (60)
Europe (40091)
Florida (351)
Georgia (39)
Idaho (9)
Illinois (204)
India (16)
Indiana (136)
Iowa (1)
Japan (97)
Kansas (59)
Kentucky (12)
Louisiana (1)
Maine (4)
Maryland (266)
Massachusetts (1564)
Michigan (36)
Minnesota (98)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (806)
New Mexico (7)
New York (540)
North Carolina (404)
North Dakota (2)
Northern California (768)
Ohio (53)
Oklahoma (4)
Oregon (16)
Pennsylvania (464)
Puerto Rico (9)
Rhode Island (10)
South America (512)
South Carolina (2)
Southern California (757)
Tennessee (34)
Texas (244)
United States (7591)
Utah (35)
Virginia (78)
Washington D.C. (31)
Washington State (126)
Wisconsin (17)
269,903 Results for "peak pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
April 17, 2025
·
2 min read
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
Immuron CEO Steven Lydeamore to present at Peak Sky High
Immuron Limited, an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will be presenting at Peak Asset Management’s Peak Sky High luncheon in Melbourne on June 1, 2024.
May 31, 2024
·
6 min read
Deals
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
Akari Therapeutics, Plc and Peak Bio Inc. announced completion of a joint portfolio prioritization review pursuant to which the combined entity, following completion of the previously announced merger of Akari and Peak, will focus on Peak’s ADC platform technology and Akari’s PAS-nomacopan Geographic Atrophy program.
May 1, 2024
·
16 min read
Press Releases
Axsendo Clinical Research (ACR) is proud to announce a new research partnership with Peak Heart & Vascular
January 15, 2025
·
1 min read
Press Releases
Oracle Recognized as a Leader in Everest Group PEAK Matrix® for Life Sciences Clinical Trial Management System (CTMS) Assessment 2024
February 3, 2025
·
5 min read
Press Releases
Bright Peak Therapeutics to Participate in 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
STERIS plc announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million.
April 11, 2024
·
9 min read
Biotech Beach
Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials
Bright Peak Therapeutics, a biotechnology company developing next-generation, multifunctional immunotherapies, announced that it raised $90 million in a Series C financing.
June 11, 2024
·
2 min read
Press Releases
Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger
November 8, 2024
·
12 min read
1 of 26,991
Next
